These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease. Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300 [TBL] [Abstract][Full Text] [Related]
11. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. Alves G; Brønnick K; Aarsland D; Blennow K; Zetterberg H; Ballard C; Kurz MW; Andreasson U; Tysnes OB; Larsen JP; Mulugeta E J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1080-6. PubMed ID: 20547614 [TBL] [Abstract][Full Text] [Related]
12. Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal study. Brockmann K; Schulte C; Deuschle C; Hauser AK; Heger T; Gasser T; Maetzler W; Berg D Parkinsonism Relat Disord; 2015 Dec; 21(12):1427-34. PubMed ID: 26475624 [TBL] [Abstract][Full Text] [Related]
13. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease. Liu C; Cholerton B; Shi M; Ginghina C; Cain KC; Auinger P; ; Zhang J Parkinsonism Relat Disord; 2015 Mar; 21(3):271-6. PubMed ID: 25596881 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Mollenhauer B; Caspell-Garcia CJ; Coffey CS; Taylor P; Shaw LM; Trojanowski JQ; Singleton A; Frasier M; Marek K; Galasko D; Neurology; 2017 Nov; 89(19):1959-1969. PubMed ID: 29030452 [TBL] [Abstract][Full Text] [Related]
15. Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease. Akhtar RS; Licata JP; Luk KC; Shaw LM; Trojanowski JQ; Lee VM J Neurochem; 2018 Jun; 145(6):489-503. PubMed ID: 29500813 [TBL] [Abstract][Full Text] [Related]
16. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset. Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]